HEALTH OF WOMAN. 2017.8(124):71–73; doi 10.15574/HW.2017.124.71  

Bysaha N. Yu.
Uzhhorod National University

The objective: study of hormonal status in pregnant women with benign cervical pathology (CP) in anamnesis.
Patients and methods. Clinical and statistical analysis of the hormonal status of 100 women with a history of benign CP pathology has been performed. According to the revealed symptoms of CP during colposcopic examination, women were divided into two groups: 100 pregnant women, in whom colposcopic and cytologically signs of CP pathology were not detected, were included in the control group; and 100 women who had a pathology of CP, entered the main group.
Results. The study examined hormonal relationships in the system mother–placenta–fetus, namely the level of hormones such as estriol, progesterone, human chorionic gonadotropin, placental lactogen. Hormonal changes in pregnant women and contribute to reducing the immunoreactivity unwanted stimulation of existing benign hyperplastic background processes in the cervix.
Conclusion. Determining functional state placenta is an important factor in the timely diagnosis of disorders in the functioning of the system mother–placenta–fetus.
Key words: hormonal status, placenta, uterine cervix, fetoplacental complex.

REFERENCES

1. Antypkin YuH. 2007. Reproduktyvne zdorovia zhinok yak vazhlyva skladova pokrashchennia demohrafichnoi sytuatsii v Ukraini. Zhurn. AMN Ukrainy 13;3:476–485.

2. Hoida NH. 2005. Analiz stanu zdorovia zhinok ta ditei v Ukraini. Mystetstvo likuvannia 10(26):12–15.

3. Zhylka N, Irkina T, Teshenko V. 2001. Stan reproduktyvnoho zdorovia v Ukraini: medyko-demohrafichnyi ohliad. K, MOZ Ukrainy, NAN Ukrainy. Instytut ekonomiky:68.

4. Zaporozhan VM, Tsehelskyi MR. 2006. Akusherstvo ta hinekolohiia. K, Zdorovia:240.

5. Kaminskyi VV, Markin LB ta in. 2008. Zberezhennia reproduktyvnoho zdorovia zhinky – osnova formuvannia zdorovoi natsii. Zdorovia Ukrainy 9:58–59.

6. Podolskyi VV. 2003. Reproduktyvne zdorovia zhinok – vazhlyva problema suchasnosti. Zdorove zhenshchynу 1(13):100–104.

7. Repina MA. 2001. Didrogesteron-progesteron uspeshnoy beremennosti. Ginekologiya 2;13:25–35.

8. Sidelnikova VM, Suhih GT. 2010. Nevyinashivanie beremennosti: Rukovodstvo dlya praktikuyuschih vrachey. M, OOO «Meditsinskoe informatsionnoe agentstvo»:536.

9. Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gyn. Endocr. 2012. Early Online: 1–8.

10. Fanchin R, Fridman R. 2001. Human Chorionic gonadotropin: Does it affect human endometrial morphology in vivo? Sem. Reproductive Med. 19(1):31–35. https://doi.org/10.1055/s-2001-13908

11. Salazar EL, Calzada L. 2007. The role of progesterone in endometrial estradiol and progesterone-receptor synthesis in women with menstrual disorders and nabitual abortion. Gynecol. Endocrinol. 23(4):222–225. https://doi.org/10.1080/09513590701254030; PMid:17505942